Yahoo Web Search

Search results

1. • 

     Actress Judi Dench says she 'can't even see' due to macular degeneration. Here's what to know about...

     Yahoo Life Style via AOL· 22 hours ago

     degeneration “may not be able to tell if the dial on the stove is turned to ‘off,’ but they can get...

2. • 

     Macular degeneration and floaters: What to know

     Medical News Today· 2 days ago

     This article discusses whether macular degeneration can cause eye floaters. This article also looks at symptoms and causes of eye floaters, diagnosis....

3. • 

     Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio

     The Wall Street Journal· 10 hours ago

     Merck’s venture arm was an investor in EyeBio. EyeBio’s lead drug, Restoret, is in development to...

4. • 

     Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence - Merck & Co...

     Benzinga· 13 hours ago

     Merck & Co., Inc. MRK is reportedly on the verge of acquiring EyeBio, an eye drug company, for a sum...

5. • South African Voters Set to Snub Mandela’s Party - What’s News - WSJ Podcasts

     The Wall Street Journal· 11 hours ago

     Peter Granitz: Chicago has an idea to save its dying downtown, give developers millions of dollars to attract tenants. Plus, Democrats have a plan to recapture the House, a $100 million in ads ...

6. • 

     2 Biotech Stocks to Buy in May

     Motley Fool via Yahoo Finance· 4 days ago

     For reference, Dupixent's sales were $11.59 billion last year. Regeneron's second-most-important product, Eylea, is at a critical point. Eylea is a...

7. • US Bancorp DE Has $4.34 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

     ETF DAILY NEWS· 12 hours ago

     US Bancorp DE grew its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.7% in the 4th quarter, according to the company in its most recent disclosure with ...

8. • Cambridge Investment Research Advisors Inc. Sells 2,003 Shares of Regeneron Pharmaceuticals, Inc....

     ETF DAILY NEWS· 13 hours ago

     Cambridge Investment Research Advisors Inc. lowered its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 19.8% during the fourth quarter, according to the company in ...

9. • Kodiak Sciences Inc. (NASDAQ:KOD) Receives $5.50 Average Price Target from Analysts

     ETF DAILY NEWS· 6 days ago

     Shares of Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) have received an average recommendation of “Reduce” from the seven analysts that are currently covering the company, Marketbeat.com ...

10. • Dynamic Technology Lab Private Ltd Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

      ETF DAILY NEWS· 7 days ago

      Dynamic Technology Lab Private Ltd purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the fourth quarter, according to the company in its most ...